Yearly Archives - 2018

Help For The Blind: Eyesight ‘restoration’ with VR

Resembling the visor worn by Geordi La Forge in Star Trek, the eSight 3 allows the legally blind to do just about anything that a fully sighted person is able to do, whether that’s reading the newspaper or playing basketball… Once you get over the impulse to perform painful Star Trek character impersonations. Our friends over at VRE (VR Hire in London) delve into the workings of the Esight headset. Read More >>
Read more...

Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will be presenting at NobleCon14 - Noble Capital Markets’ Fourteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 29th at 11:00 AM EST - Studio 4. Chairman and Chief Executive Officer Paul R. Gudonis will be presenting, as well as meeting with investors. Read more >>
Read more...

3 Game-Changing Health Gadgets Spotted at CES

In advance of CES, I was alerted to two products in this category that I wanted to check out. The first is called eSight, which are electronic glasses that let the legally blind see. In the demo I saw, a legally blind woman using these glasses could see the street from the 30th floor of a hotel suite and make out what people were wearing at street level. Read more >>
Read more...

From Startup to Publicly Traded Company: Story of Corbus Pharmaceuticals

The following post is from Antonette Ho, Group Operations Manager at Boston Harbor Angels. Corbus Pharmaceuticals Wins Exit of the Year Award Corbus Pharmaceuticals is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. One of the great successes in the Boston Harbor Angels portfolio, Corbus was awarded Exit of the Year at the annual end-of-year general meeting in December 2017. Yuval Cohen, CEO of Corbus Pharmaceuticals and Mark Tepper, President &...
Read more...